Latest Incyte News & Updates

See the latest news and media coverage for Incyte. We track all announcements, press releases, and industry mentions in real time, all in one place.

Incyte

Biopharmaceutical company developing medicines for serious diseases

incyte.com

Headquarters: Wilmington, United States
Company type: Public company
Number of employees: 3,500–5,000
Industry: Pharmaceuticals

Last updated Today

Latest news about Incyte

In short: Incyte reported strong Q2 2026 growth, raised its revenue outlook, acquired Vega Therapeutics, and received EU approval for Opzelura.

Company announcements

July 29 Incyte

Incyte received EU approval for Opzelura cream for atopic dermatitis

The European Commission approved it as the first steroid-free topical JAK inhibitor for adults with moderate disease, based on Phase 3b data.

July 28 Incyte

Incyte reports second quarter 2026 financial results

Total revenue of $1.67 billion with 38% growth, and updated guidance for 2026.

July 23 Incyte

Incyte publishes Phase 3 HS data

The data appeared in a Nature Medicine publication from the STOP-HS trials.

July 11 Incyte

Incyte reports 81% median bleed reduction with VGA039 in VWD

Data from Phase 1/2 multidose study showed safe and effective prophylaxis with once-monthly subcutaneous dosing.

Media coverage

September 9 RTTNews

Incyte Corporation, FDA Calendar, PDUFA Date

Incyte Corporation (INCY) FDA Update for Drug Zlurgisertib (NDA) and scheduled decision/review of PDUFA date.

September 4 Ad hoc news

Incyte stock follows strong Q2 figures

Incyte stock benefits from a strong second quarter of 2026 with $1.67 billion in revenue and $3.09...

September 3 Ad hoc news

Incyte stock gains as latest results highlight double digit revenue growth

Incyte stock is trading higher as investors digest double digit revenue growth and updated guidance from the biotech company, with the latest quarterly figures and...

August 31 The Globe and Mail

Incyte Reaches CMS Pact on Jakafi Medicaid Pricing

An announcement from Incyte ( ) is now available. Incyte Corporation said it has entered into an agreement with the U.S. Centers for Medicare ...

Never miss news about Incyte

Track Incyte and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Incyte competitors & trending companies

Browse news for competitors to Incyte and other trending companies.